Nephris

NephroGenex (BioStratum, Inc.)

This pharmaceutical company develops therapies to treat kidney disease, including a drug candidate for patients with diabetic nephropathy.

Nephraegis Therapeutics

Nephraegis Therapeutics develops small molecule drugs to prevent and treat acute kidney injury for patients undergoing cardiovascular and abdominal surgical procedures.

Neotis

This company develops immunotherapies targeting senescent cells to treat age-related and fibrotic diseases for patients with chronic conditions.

Purespring Therapeutics

This company develops gene therapies for patients with chronic renal diseases to preserve kidney function and treat conditions like IgA nephropathy.

Thrasos

This biotherapeutics company develops targeted peptide therapies for the prevention and treatment of kidney diseases for patients with acute and chronic renal conditions.

Trestle Biotherapeutics

This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.

Chinook Therapeutics

This biopharmaceutical company develops precision medicines for patients with rare and severe chronic kidney diseases.

Nephrolyx

Nephrolyx develops diagnostic test kits and a digital platform for precise kidney function measurement to help clinicians and laboratories detect renal diseases.